MobiHealth News October 1, 2020
Valo Health’s Opal Computational Platform uses machine learning, cloud computing and real-world data to assist in the drug discovery and development process.
Flagship Pioneering recently launched its latest company, Valo Health, which has a drug-discovery technology platform.
Valo’s Opal Computational Platform uses machine learning, cloud computing and real-world data to assist in the drug-discovery and development process. It is currently focusing on treatments for cardiovascular diseases, neurodegeneration and cancer.
The platform works by first identifying drug candidates for a certain disease. From there, it evaluates both new and known molecules to estimate how they will react within the body while predicting which patients will see the best results. Additionally, Opal can design the clinical trials needed to test its hypotheses.
...